Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pharmala Biotech Holdings Inc MDXXF


Primary Symbol: C.MDMA

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:MDMA)

PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

GlobeNewswire 7 days ago

Canadian psychedelic stock to supply MDMA to Yale

Trevor Abes  November 7, 2024

PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

GlobeNewswire November 7, 2024

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA

GlobeNewswire October 21, 2024

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo(TM) MDMA

GlobeNewswire October 8, 2024

PharmAla to supply Harvard Medical School trial with MDMA

Jonathon Brown October 2, 2024

PharmAla to supply Harvard Medical School's Maclean Hospital with LaNeo MDMA

GlobeNewswire October 2, 2024

PharmAla to supply Johns Hopkins Medicine for Clinical Trial

GlobeNewswire September 11, 2024

PharmAla Launches MDMA Clinical Trial Tool for Researchers

GlobeNewswire August 22, 2024
View More News ››

Opinion & Analysis (CSE:MDMA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:MDMA)

News Releases

I'm going to guess that we may not get the agreement signed and announced until after the financials are released.   And we may...
inviolablspirit - 6 hours ago

RE:Pharmala

It's amazing how many investors begin to freak out (i.e. those on CEO) when a stock pulls back.  No stock goes straight up...
inviolablspirit - 8 hours ago

RE:RE:Pharmala

It's very clear you're not invested here and you're looking for scalping opportunities and trading opportunities and pumping...
Chefboy69 - 1 day ago

RE:Pharmala

Does anybody know if Pharmala Biotech has ever been mentioned on BNN???   Has anyone phoned in about the stock?  Just curious...
inviolablspirit - 1 day ago

Pharmala

I've noticed that there is very little to no coverage of Pharmala.  It's not on any stock pick lists or in newslettters...
inviolablspirit - 3 days ago

RE:Financials

Pharmala's Year-End is August 31, 2024 On a venture exchange these are the filing dates: Year End Filing date is Dec 30, 2024 Q1...
inviolablspirit - 3 days ago
View more Bullboard ››

Tenet Fintech Group Inc.

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial ...
View More »